Cargando…
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
BACKGROUND: Clinicians are less likely to prescribe guideline-recommended treatments to people with multimorbidity than to people with a single condition. Doubts as to the applicability of clinical trials of drug treatments (the gold standard for evidence-based medicine) when people have co-existing...
Autores principales: | Hanlon, Peter, Hannigan, Laurie, Rodriguez-Perez, Jesus, Fischbacher, Colin, Welton, Nicky J., Dias, Sofia, Mair, Frances S., Guthrie, Bruce, Wild, Sarah, McAllister, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849229/ https://www.ncbi.nlm.nih.gov/pubmed/31711480 http://dx.doi.org/10.1186/s12916-019-1427-1 |
Ejemplares similares
-
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
por: Hanlon, Peter, et al.
Publicado: (2023) -
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis
por: Butterly, Elaine W., et al.
Publicado: (2023) -
Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis
por: Crowther, Jamie, et al.
Publicado: (2023) -
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
por: Hanlon, Peter, et al.
Publicado: (2022) -
Improving the Estimation of Subgroup Effects for Clinical Trial
Participants with Multimorbidity by Incorporating Drug Class-Level Information
in Bayesian Hierarchical Models: A Simulation Study
por: Hannigan, Laurie J., et al.
Publicado: (2021)